Cannabis Zelira launches new fast acting capsule and tablet technology Company claims its innovative patented tech will accelerate dissolution rates of distillate when administered orally Rowan DunneSeptember 20, 2022
Psychedelics MindMed doses first patient with MDMA-like compounds in new trial New study will compare the effects of MDA and MDMA in humans for the first time Rowan DunneSeptember 20, 2022
Cannabis Kiva launches market donation program to prevent cannabis waste New initiative aims to donate over 70K edibles to medical patients in California Rowan DunneSeptember 20, 2022
Research World melatonin market to hit US$4 billion by 2028: SkyQuest Increasing rates of stress, insomnia and other sleep disorders around the globe will propel market growth Rowan DunneSeptember 19, 2022
Canada Freedom Cannabis acquires assets of Boaz Pharma Acquisition will expand Freedom's production capacity and lower its production costs Rowan DunneSeptember 19, 2022
Business International CBD-infused wine market to hit US$113M by 2031: AMR Legalization of cannabis in multiple countries such as the U.S., Canada and Australia will be primary driver of market growth Rowan DunneSeptember 19, 2022
Business Cookies and Cirona Labs work together on products for rapid onset New collaborative product line will launch this fall across the U.S. Rowan DunneSeptember 16, 2022
Business Ovation Science receives patent for Invisicare drug delivery system Company considers patent to be significant achievement for R&D department Rowan DunneSeptember 16, 2022
Canada ATMA receives Health Canada approval for new psilocybin trial Study will evaluate psilocybin efficacy in healthcare workers with mental health challenges related to pandemic Rowan DunneSeptember 15, 2022
Stock News MindMed re-establishes Nasdaq listing requirements News follows a 1-for-15 reverse share split by the company at the end of August and ensuing loss of stock value Rowan DunneSeptember 14, 2022